Tokyo, Japan

Kazuya Takanashi

USPTO Granted Patents = 4 


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2004-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kazuya Takanashi: Innovator in Pharmaceutical Composition

Introduction

Kazuya Takanashi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions. With a total of 4 patents to his name, Takanashi's work has had a meaningful impact on the industry.

Latest Patents

One of Takanashi's latest patents is for a ciclesonide-containing aqueous pharmaceutical composition. This invention provides an aqueous pharmaceutical composition that includes ciclesonide and hydroxypropyl-methylcellulose. The composition is designed to maintain consistent concentrations of ciclesonide during production and improve the recovery rate of the compound. Another significant patent is for a ciclesonide-containing sterile aqueous suspension. This invention outlines methods for manufacturing a sterile suspension through autoclaving, ensuring the integrity and safety of the product.

Career Highlights

Throughout his career, Takanashi has worked with prominent companies in the pharmaceutical sector. He has been associated with Nycomed GmbH and Altana Pharma AG, where he has contributed to various projects and innovations. His expertise in pharmaceutical formulations has been instrumental in advancing the development of effective medications.

Collaborations

Takanashi has collaborated with several professionals in his field, including Atsuhiro Nagano and Yoshihisa Nishibe. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical solutions.

Conclusion

Kazuya Takanashi is a distinguished inventor whose work in pharmaceutical compositions has paved the way for advancements in medication formulation. His patents reflect a commitment to improving drug delivery systems and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…